Shares of Ubisoft (UBI.FR), French video game company, are slumping almost 20% in today's trading. Poor performance of the company's stock can be blamed on Ubisoft cutting booking targets for the third quarter of fiscal 2022/23 (October 2022 - December 2022). Company noted that its recent launches have not performed as well as expected amid a more challenging environment and that its next big titles, which are expected to be earnings drivers, are yet to be released. Ubisoft also highlighted that sales during the Christmas holiday period were slower than expected.
Given the deteriorating situation, Ubisoft decided to review its business prospects and focus on the most promising titles. As such, the company said it has decided to cancel 3 projects that were unannounced yet, following cancellations of 4 other projects back in July 2022. Ubisoft also announced another delay to the Skull and Bones title, which is now expected to be released in early 2023/2024 fiscal year (April 2023 - March 2024).
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appUbisoft has revised its net bookings target for fiscal-Q3 2022/2023 and now expects them at approximately €725 million, down from €830 million. A massive revision was also made to full-year targets with net bookings now expected to be down 10% while the previous forecast called for a 10% growth.
Shares of Ubisoft (UBI.FR) plunged almost 20% today and drop to 7-year low after company cut its net bookings targets for fiscal Q3 and full fiscal-2022/2023. The €19.00 support area was tested earlier today but bulls managed to fend off the bears, at least for now. Source: xStation5
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
